Search Results - "Koda, Joy E"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies by Roth, Jonathan D, Roland, Barbara L, Cole, Rebecca L, Trevaskis, James L, Weyer, Christian, Koda, Joy E, Anderson, Christen M, Parkes, David G, Baron, Alain D

    “…Body weight is regulated by complex neurohormonal interactions between endocrine signals of long-term adiposity (e.g., leptin, a hypothalamic signal) and…”
    Get full text
    Journal Article
  2. 2

    Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy by Ravussin, Eric, Smith, Steven R., Mitchell, Julie A., Shringarpure, Reshma, Shan, Kevin, Maier, Holly, Koda, Joy E., Weyer, Christian

    Published in Obesity (Silver Spring, Md.) (01-09-2009)
    “…The neurohormonal control of body weight involves a complex interplay between long‐term adiposity signals (e.g., leptin), and short‐term satiation signals…”
    Get full text
    Journal Article
  3. 3

    Interaction of Leptin and Amylin in the Long-term Maintenance of Weight Loss in Diet-induced Obese Rats by Trevaskis, James L, Lei, Chunli, Koda, Joy E, Weyer, Christian, Parkes, David G, Roth, Jonathan D

    Published in Obesity (Silver Spring, Md.) (01-01-2010)
    “…We have previously shown that combined amylin + leptin agonism elicits synergistic weight loss in diet-induced obese (DIO) rats. Here, we assessed the…”
    Get full text
    Journal Article
  4. 4

    Hyperamylinemia, Hyperinsulinemia, and Insulin Resistance in Genetically Obese LA/N-cp Rats by Huang, Huei-Jen Su, Young, Andrew A, Koda, Joy E, Tulp, Orien L, Johnson, M Jacqueline, Cooper, Garth J.S

    Published in Hypertension (Dallas, Tex. 1979) (01-01-1992)
    “…The experimental evidence supporting a direct role for hyperinsulinemia as a cause of insulin resistance remains equivocal. Amylin, an islet β-cell peptide…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker by Bray, K R, Koda, J E, Gaur, P K

    Published in Cancer research (Chicago, Ill.) (15-11-1987)
    “…CA-549 is a circulating breast cancer-associated antigen that reacts with monoclonal antibody BC4E 549. Biochemical characterization of CA-549 revealed that it…”
    Get full text
    Journal Article
  6. 6

    Development of sensitive immunoassays to detect amylin and amylin-like peptides in unextracted plasma by Percy, AJ, Trainor, DA, Rittenhouse, J, Phelps, J, Koda, JE

    Published in Clinical chemistry (Baltimore, Md.) (01-04-1996)
    “…Amylin is a 37-amino-acid polypeptide synthesized in and secreted from pancreatic beta cells along with insulin. Its biological actions include the slowing and…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Preclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin by Young, Andrew A., Vine, William, Gedulin, Bronislava R., Pittner, Richard, Janes, Susan, Gaeta, Laura S.L., Percy, Amy, Moore, Candace X., Koda, Joy E., Rink, Timothy J., Beaumont, Kevin

    Published in Drug development research (01-04-1996)
    “…The pancreatic β‐cell hormone, amylin, is absent or reduced in individuals with type I diabetes mellitus and in many insulin‐treated patients with type II…”
    Get full text
    Journal Article
  9. 9

    Molecular physiology of amylin by Pittner, R A, Albrandt, K, Beaumont, K, Gaeta, L S, Koda, J E, Moore, C X, Rittenhouse, J, Rink, T J

    Published in Journal of cellular biochemistry (1994)
    “…Amylin is a 37-amino acid peptide first isolated, purified, and characterized from the amyloid deposits in the pancrease of type 2 diabetics. It is synthesized…”
    Get more information
    Journal Article
  10. 10